Biren Amin
Stock Analyst at Piper Sandler
(1.95)
# 2,939
Out of 4,711 analysts
49
Total ratings
34.09%
Success rate
-4.51%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Biren Amin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VKTX Viking Therapeutics | Initiates: Overweight | $74 | $42.25 | +75.15% | 1 | Dec 2, 2024 | |
| CRBP Corbus Pharmaceuticals Holdings | Initiates: Overweight | $35 | $13.00 | +169.23% | 1 | Dec 2, 2024 | |
| SRPT Sarepta Therapeutics | Maintains: Overweight | $200 → $182 | $118.97 | +52.98% | 5 | Nov 27, 2024 | |
| IMNM Immunome | Maintains: Overweight | $23 → $21 | $10.97 | +91.43% | 3 | Nov 14, 2024 | |
| ALLO Allogene Therapeutics | Maintains: Overweight | $11 → $9 | $1.87 | +381.28% | 2 | Nov 14, 2024 | |
| ACLX Arcellx | Maintains: Overweight | $91 → $115 | $75.54 | +52.24% | 2 | Nov 8, 2024 | |
| APLS Apellis Pharmaceuticals | Maintains: Neutral | $40 → $32 | $33.21 | -3.64% | 2 | Nov 6, 2024 | |
| BBIO BridgeBio Pharma | Initiates: Overweight | $46 | $26.49 | +73.65% | 1 | Sep 4, 2024 | |
| CRGX CARGO Therapeutics | Maintains: Overweight | $37 → $34 | $14.90 | +128.19% | 2 | Aug 13, 2024 | |
| AGEN Agenus | Downgrades: Hold | $7 → $3 | $2.83 | +6.01% | 1 | Jul 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $20 | $4.16 | +380.77% | 1 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 | $8.50 | +76.47% | 1 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $10 | $0.58 | +1,624.14% | 1 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 → $70 | $3.00 | +2,233.33% | 2 | May 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $51 | $0.69 | +7,266.75% | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $4.88 | +391.80% | 1 | Oct 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $34 | $1.85 | +1,737.84% | 1 | Oct 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $1,050 → $500 | $5.92 | +8,345.95% | 2 | Sep 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $6.85 | +104.38% | 1 | Jul 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $657 → $691 | $701.85 | -1.55% | 2 | Jun 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $16 → $10 | $1.09 | +817.43% | 1 | Jun 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $8.50 | - | 4 | Dec 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $101 | $14.55 | +594.16% | 1 | Nov 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $66 → $69 | $135.42 | -49.05% | 1 | Oct 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $155 | $397.27 | -60.98% | 5 | Jul 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $136 | $2.16 | +6,196.30% | 4 | Mar 6, 2017 |
Viking Therapeutics
Dec 2, 2024
Initiates: Overweight
Price Target: $74
Current: $42.25
Upside: +75.15%
Corbus Pharmaceuticals Holdings
Dec 2, 2024
Initiates: Overweight
Price Target: $35
Current: $13.00
Upside: +169.23%
Sarepta Therapeutics
Nov 27, 2024
Maintains: Overweight
Price Target: $200 → $182
Current: $118.97
Upside: +52.98%
Immunome
Nov 14, 2024
Maintains: Overweight
Price Target: $23 → $21
Current: $10.97
Upside: +91.43%
Allogene Therapeutics
Nov 14, 2024
Maintains: Overweight
Price Target: $11 → $9
Current: $1.87
Upside: +381.28%
Arcellx
Nov 8, 2024
Maintains: Overweight
Price Target: $91 → $115
Current: $75.54
Upside: +52.24%
Apellis Pharmaceuticals
Nov 6, 2024
Maintains: Neutral
Price Target: $40 → $32
Current: $33.21
Upside: -3.64%
BridgeBio Pharma
Sep 4, 2024
Initiates: Overweight
Price Target: $46
Current: $26.49
Upside: +73.65%
CARGO Therapeutics
Aug 13, 2024
Maintains: Overweight
Price Target: $37 → $34
Current: $14.90
Upside: +128.19%
Agenus
Jul 19, 2024
Downgrades: Hold
Price Target: $7 → $3
Current: $2.83
Upside: +6.01%
Jun 21, 2024
Reiterates: Overweight
Price Target: $20
Current: $4.16
Upside: +380.77%
Jun 21, 2024
Maintains: Overweight
Price Target: $15
Current: $8.50
Upside: +76.47%
May 31, 2024
Initiates: Overweight
Price Target: $10
Current: $0.58
Upside: +1,624.14%
May 19, 2023
Maintains: Buy
Price Target: $120 → $70
Current: $3.00
Upside: +2,233.33%
Jan 11, 2021
Initiates: Buy
Price Target: $51
Current: $0.69
Upside: +7,266.75%
Oct 30, 2020
Initiates: Buy
Price Target: $24
Current: $4.88
Upside: +391.80%
Oct 19, 2020
Initiates: Buy
Price Target: $34
Current: $1.85
Upside: +1,737.84%
Sep 14, 2020
Downgrades: Hold
Price Target: $1,050 → $500
Current: $5.92
Upside: +8,345.95%
Jul 24, 2020
Initiates: Buy
Price Target: $14
Current: $6.85
Upside: +104.38%
Jun 12, 2020
Maintains: Buy
Price Target: $657 → $691
Current: $701.85
Upside: -1.55%
Jun 1, 2020
Downgrades: Hold
Price Target: $16 → $10
Current: $1.09
Upside: +817.43%
Dec 11, 2017
Upgrades: Buy
Price Target: n/a
Current: $8.50
Upside: -
Nov 9, 2017
Initiates: Buy
Price Target: $101
Current: $14.55
Upside: +594.16%
Oct 3, 2017
Maintains: Buy
Price Target: $66 → $69
Current: $135.42
Upside: -49.05%
Jul 11, 2017
Initiates: Buy
Price Target: $155
Current: $397.27
Upside: -60.98%
Mar 6, 2017
Initiates: Buy
Price Target: $136
Current: $2.16
Upside: +6,196.30%